MiMedx Correlations

MDXG Stock

USD 9.16 0.28 2.97%

The current 90-days correlation between MiMedx Group and Stoke Therapeutics is -0.17 (i.e., Good diversification). The correlation of MiMedx is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

MiMedx Correlation With Market

Significant diversification

The correlation between MiMedx Group and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MiMedx Group and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Moving together with MiMedx Stock

0.82	DYAI	Dyadic International	Pair Corr
0.77	ESPR	Esperion Therapeutics	Pair Corr
0.81	BMY	Bristol Myers Squibb	Pair Corr
0.69	GILD	Gilead Sciences	Pair Corr
0.75	MNMD	Mind Medicine	Pair Corr
0.62	ABCL	Abcellera Biologics	Pair Corr

Moving against MiMedx Stock

0.93	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.92	VALN	Valneva SE ADR	Pair Corr
0.85	ERNA	Eterna Therapeutics	Pair Corr
0.85	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.85	LLY	Eli Lilly	Pair Corr
0.8	GNFT	Genfit	Pair Corr
0.72	IMAB	I Mab	Pair Corr
0.7	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.56	INBX	Inhibrx Symbol Change	Pair Corr
0.47	SLS	Sellas Life Sciences	Pair Corr
0.9	AMGN	Amgen Inc	Pair Corr
0.86	MRVI	Maravai Lifesciences	Pair Corr
0.85	REGN	Regeneron Pharmaceuticals	Pair Corr
0.75	ABBV	AbbVie Inc	Pair Corr
0.74	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.69	AKAN	Akanda Corp	Pair Corr
0.64	RANI	Rani Therapeutics	Pair Corr
0.61	MBIO	Mustang Bio	Pair Corr
0.53	NUVL	Nuvalent	Pair Corr
0.44	ABOS	Acumen Pharmaceuticals	Pair Corr
0.35	INKT	Mink Therapeutics	Pair Corr
0.31	ALVO	Alvotech	Pair Corr
0.93	TFFP	Tff Pharmaceuticals	Pair Corr
0.79	TTOO	T2 Biosystms	Pair Corr
0.77	BCDA	Biocardia	Pair Corr
0.75	APGE	Apogee Therapeutics,	Pair Corr
0.7	TCRX	Tscan Therapeutics	Pair Corr
0.69	ANRO	Alto Neuroscience,	Pair Corr

Related Correlations Analysis

	GLUE	DSGN	HOWL	IKNA	STOK	IPSC	EWTX	CCCC	MLYS	CGEM
GLUE		0.66	-0.25	0.06	0.06	-0.4	0.35	-0.55	0.14	-0.58	GLUE
DSGN	0.66		-0.13	0.06	0.39	-0.07	0.23	-0.3	0.06	-0.37	DSGN
HOWL	-0.25	-0.13		0.2	0.14	0.17	0.25	0.57	0.4	0.46	HOWL
IKNA	0.06	0.06	0.2		0.06	0.07	0.31	0.27	0.37	0.36	IKNA
STOK	0.06	0.39	0.14	0.06		0.31	-0.32	0.51	-0.1	0.46	STOK
IPSC	-0.4	-0.07	0.17	0.07	0.31		-0.39	0.41	-0.05	0.48	IPSC
EWTX	0.35	0.23	0.25	0.31	-0.32	-0.39		-0.12	0.67	-0.21	EWTX
CCCC	-0.55	-0.3	0.57	0.27	0.51	0.41	-0.12		0.17	0.91	CCCC
MLYS	0.14	0.06	0.4	0.37	-0.1	-0.05	0.67	0.17		0.11	MLYS
CGEM	-0.58	-0.37	0.46	0.36	0.46	0.48	-0.21	0.91	0.11		CGEM
	GLUE	DSGN	HOWL	IKNA	STOK	IPSC	EWTX	CCCC	MLYS	CGEM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CGEM	+ 0.91	CCCC
MLYS	+ 0.67	EWTX
DSGN	+ 0.66	GLUE
CCCC	+ 0.57	HOWL
CCCC	+ 0.51	STOK
CGEM	+ 0.48	IPSC

High negative correlations

CGEM	- 0.58	GLUE
CCCC	- 0.55	GLUE
IPSC	- 0.4	GLUE
EWTX	- 0.39	IPSC
CGEM	- 0.37	DSGN
EWTX	- 0.32	STOK

Risk-Adjusted Indicators

There is a big difference between MiMedx Stock performing well and MiMedx Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MiMedx's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
GLUE	5.35	0.92	0.16	(2.13)	4.34	(7.37)	8.40	(8.46)	103.72
DSGN	4.07	0.13	0.04	0.12	5.76	(4.08)	8.54	(8.80)	33.11
HOWL	4.53	(0.43)	0.00	(0.14)	0.00	0.00	8.54	(8.55)	49.02
IKNA	0.92	(0.13)	0.00	(0.11)	0.00	0.00	1.80	(1.74)	6.49
STOK	2.58	(0.32)	0.00	(0.12)	0.00	0.00	5.57	(5.08)	21.35
IPSC	4.01	(0.28)	0.00	(0.33)	0.00	0.00	7.44	(7.41)	28.48
EWTX	3.70	0.86	0.26	0.38	3.03	(4.30)	6.65	(5.54)	61.90
CCCC	3.65	(0.55)	0.00	(0.68)	0.00	0.00	9.28	(7.99)	23.66
MLYS	2.84	0.16	0.01	(0.16)	3.45	(2.96)	7.51	(5.79)	20.98
CGEM	2.87	(0.73)	0.00	(0.29)	0.00	0.00	5.88	(7.24)	17.85

MiMedx Corporate Management

Matthew Notarianni	Head Relations	Profile
Todd Newton	Interim Director	Profile
William Phelan	VP Officer	Profile
Kim Moller	Chief Officer	Profile
William IV	General Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC